Europe is plunging into recession as politicians row over plans to tackle its sovereign debt crisis ahead of Wednesday's key summit, alarming new figures show... more
European shares fall in early trade, snapping a four-day rally, in cautious trading ahead of Slovakia's key vote in Slovakia on the eurozone rescue fund... more
A global share rout sends the FTSE 100 plunging back towards the 5000 mark as fresh alarm over vanishing European growth follows emergency action to prop up the US economy... more
Despite the raging European crisis, until two weeks ago markets seemed to be taking most other challenges in their stride. But suddenly a number of things have erupted to cause a loss of confidence among investors... more
So veteran banker Lord Rothschild believes that the boom in commodities could be coming to an end. In his annual address to shareholders of his RIT Capital Partners investment trust, Rothschild said: "After a decade of commodity leadership, a shift to a new regime is a possibility"... more
AstraZeneca’s bill to pay off one of its biggest legal headaches hits £877 million as the drugs giant settles thousands of US claims over Seroquel... more
GlaxoSmithKline posts a £304 million second-quarter loss after £1.57 billion in costs for settling several legal cases over drugs including diabetes treatment Avandia... more
Greece’s leading central banker urges the government to slash the country’s crippling debts even faster than planned to prevent a rout on the financial markets... more
Analysis: Convenient timing? Just before posting eye-wateringly high profit, GlaxoSmithKline announces plans to slash the cost of medicine to the world's poorest people... more
Cadbury shares raced to another record high this morning as investors bet that a fierce bidding war for control of the 185-year old company is about to breakout... more
Having waited since 7am with eyes glued to their trading screens for this afternoon’s announcement, investors and stockbrokers were disappointed by the terms on offer... more
Shire has struck a deal with GlaxoSmithKline, the world's second largest drugs group, to co-promote its hyperactivity medicine Vyvanse in the United States, sending its shares sharply higher... more
Brace yourself to feel irritated. The next three months, March in particular, will see the publication of hundreds of annual reports as companies pass their financial year-ends... more
While Alistair Darling was fleshing out his plans to save the UK economy yesterday, Barack Obama was unveiling the team he wants to help him save the American one... more
Afternoon:
8°c
